Ibupro­fen ‘cuts can­cer risk’

The Scottish Mail on Sunday - - Health -

THE painkiller ibupro­fen can cut the risk of bowel can­cer by more than a quar­ter, a ma­jor new study shows.

Re­searchers from Spain and Ser­bia trawled through data from one mil­lion peo­ple and found that reg­u­lar use of the pop­u­lar over-the-counter drug pro­tected some groups against the dis­ease – es­pe­cially women and those over 40.

Ibupro­fen be­longs to a class of drugs called non-steroidal anti-in­flam­ma­tory drugs, or NSAIDS.

The the­ory is that ibupro­fen sti­fles tu­mour de­vel­op­ment by damp­en­ing in­flam­ma­tion in the bowel.

Aspirin, also an NSAID, was not part of the study be­cause of its links to stom­ach bleeds.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.